Found: 6
Select item for more details and to access through your institution.
Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 662, doi. 10.1007/s10637-010-9604-2
- By:
- Publication type:
- Article
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 4, p. 537, doi. 10.1111/j.1365-2125.2010.03729.x
- By:
- Publication type:
- Article
Population pharmacokinetics modeling and analysis of foretinib in adult patients with advanced solid tumors.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 10, p. 1184, doi. 10.1002/jcph.546
- By:
- Publication type:
- Article
Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin-1 Receptor Antagonist.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 8, p. 951, doi. 10.1177/0091270009353761
- By:
- Publication type:
- Article
Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 5, p. 566, doi. 10.1177/0091270009346965
- By:
- Publication type:
- Article